AI assistant
Sending…
CSPC Pharmaceutical Group Limited — Earnings Release 2003
Mar 22, 2004
49680_rns_2004-03-22_5eec70d3-411c-418d-9c33-3797c521035e.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| CHINA PHARMA<01093> - Results Announcement (Summary) China Pharmaceutical Group Limited announced on 22/3/2004: (stock code: 01093 ) Year end date: 31/12/2003 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 1/1/2003 from 1/1/2002 to 31/12/2003 to 31/12/2002 Note ('000 ) ('000 ) Turnover : 2,478,426 1,625,130 Profit/(Loss) from Operations : 618,289 297,891 Finance cost : (25,361) (26,682) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 7,610 7,916 Profit/(Loss) after Tax & MI : 504,169 228,142 % Change over Last Period : +121 % EPS/(LPS)-Basic (in dollars) : 0.3327 0.1662 -Diluted (in dollars) : 0.3283 0.1635 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 504,169 228,142 Final Dividend : HK 7.0 cents HK 6.0 cents per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 10/5/2004 to 14/5/2004 bdi. Payable Date : 28/5/2004 B/C Dates for Annual General Meeting : 10/5/2004 to 14/5/2004 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Profit from operations 2003 2002 HK$'000 HK$'000 Profit from operations has been arrived at after charging (crediting): Amortisation of intangible assets 13,770 14,303 Amortisation of goodwill 3,168 1,546 Depreciation of property, plant and equipment 129,024 103,818 Impairment of intangible assets 10,878 - Bank interest income (1,589) (1,737) ======== ======== 2. Earnings per share The calculation of the basic and diluted earnings per share is based on the following data: 2003 2002 Profit attributable to shareholders HK$504,169,000 HK$228,142,000 ================= ============== Weighted average number of ordinary shares for the purposes of basic earnings per share 1,515,192,387 1,373,033,290 Effect of dilutive potential ordinary shares in respect of share options 20,501,401 22,612,855 ----------------- ------------- Weighted average number of ordinary shares for the purposes of diluted earnings per share 1,535,693,788 1,395,646,145 ================= ============= |
More from CSPC Pharmaceutical Group Limited
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Governance Information
2026
May 28
Interim / Quarterly Report
2026
May 27
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
